World News: 18:48 GMT Wednesday 17th April 2019. [Market Research Future via Globe Newswire via SPi World News]
Pune, India, April 17, 2019 (GLOBE NEWSWIRE) -- Global Cell Isolation Market is projected to exceed a valuation of USD 10,500 million by 2023, as per the latest report by Market Research Future (MRFR). The application of the technique in discerning the response of cells to various drugs is expected to be the major driver of the market. Furthermore, the advocation of the technique by physicians and clinicians is a clear indicator of market prospects.
Cell isolation, also known as cell separation, is a technique used in extracting specific cells from a tissue or cell culture. This method is vital in isolating nuclei and mitochondria which can be used in reducing the volume of blood components.
Prevalence of cancer and chronic diseases as well as funding by private and government organizations are other drivers of the market. In May 2018, researchers from the University of Massachusetts, U.S., had developed a mitochondrial isolation technique by fusing three genes.
Personalized medicine is an upcoming therapy required for devising treatments and drugs according to the individual. The cell separation techniques are used in detecting diseases at a preventive stage and determining the appropriate prognosis.
Prominent market players include Bio-Rad Laboratories Inc., Merck KGaA, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, TERUMO CORPORATION, STEMCELL Technologies, Becton, Dickinson and Company, Miltenyi Biotec, GE Healthcare, and Beckman Coulter.
Partnerships are at an all-time high with major companies allying to gain a competitive edge in the market. Lonza and AllCells have partnered with each other for launching hematopoietic cell lines. The cells play a major role in advancing in vivo research and assist scientists in performing cell isolation tests.
Biological research has been the cornerstone to finding solutions to major diseases affecting the populace. The Lonza Group decided to launch CellBio Services, a portfolio of products and customized solutions designed to expedite research development in organizations and institutes. It has products for separating tissues of porcine, murine, canine, feline, primate, and human.
The global cell isolation market is segmented by cell type, technique, product, application, and end-user.
By cell type, the market is segmented into animal and human cells. The latter accounted for a major market share in 2017 due to focus on cancer research and stem cell therapy. It can exhibit a stellar 17.4% CAGR during the forecast period.
Techniques include centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. The centrifugation-based cell isolation segment is expected to generate the maximum revenue for the market due to being cost-effective for research institutes. It can exhibit 17.3% CAGR over the review period.
Products used in the cell isolation market include consumables and instruments. Consumables held the lion’s share of the market with a valuation of USD 2,343.3 million in 2017. It can exhibit 17.5% CAGR over the forecast period due to availability of ready-to-use cells which can be used for testing purposes.
Major applications include therapeutics, stem cell research, cancer research, biomolecule isolation, in vitro diagnostics, and tissue regeneration. Biomolecule isolation is predicted to be the biggest application due to massive investments in biotechnology and inclination towards development of biologics. On the other hand, the cancer research segment is anticipated to expand at 17.6% CAGR over the forecast period.
By end-user, the market is segmented into cell banks, hospitals & diagnostic laboratories, biotechnology & biopharmaceutical companies, and research laboratories & institutes. Biotechnology & biopharmaceutical companies can exhibit a 17.7% CAGR during the review period due to increasing prevalence of chronic ailments and dire need for rapid solutions.
Regions taken under consideration with respect to the market include the Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA).
The Americas possess the potential for massive growth due to regions of the U.S. and Canada in North America. High prevalence of chronic diseases, inflated budget for R&D, and rising demand for appropriate solutions are factors influencing the regional market growth. The advanced healthcare infrastructure in Canada and the U.S. can bolster the market demand significantly.
The APAC cell isolation market is expected to exhibit 17.7% CAGR over the assessment period due to initiatives by governments to upgrade the healthcare sector in developing economies. The large patient pool and huge geriatric populace in China, India, Malaysia, Australia, and Singapore can drive the regional market demand.
Browse Related Reports:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Globe Newswire: 18:48 GMT Wednesday 17th April 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.